These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 37643021)

  • 1. LRRK2; Communicative Role in the Treatment of Parkinson's Disease and Ulcerative Colitis Overlapping.
    Lashgari NA; Roudsari NM; Niknejad A; Shamsnia HS; Shayan M; Shalmani LM; Momtaz S; Rezaei N; Abdolghaffari AH
    CNS Neurol Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38279762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of leucine-rich repeat kinase 2 in severe acute pancreatitis.
    Otsuka Y; Minaga K; Kudo M; Watanabe T
    Front Immunol; 2024; 15():1364839. PubMed ID: 38440723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel C-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson's Disease.
    Sabnis RW; Sabnis AR
    ACS Med Chem Lett; 2023 Jun; 14(6):698-699. PubMed ID: 37312864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of LRRK2 in the Treatment of Parkinson's Disease.
    Kargbo RB
    ACS Med Chem Lett; 2020 Nov; 11(11):2070-2071. PubMed ID: 33214810
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitors of LRRK2 as Treatment for Parkinson's Disease: Patent Highlight.
    Abdel-Magid AF
    ACS Med Chem Lett; 2012 Sep; 3(9):701-2. PubMed ID: 24900536
    [No Abstract]   [Full Text] [Related]  

  • 6. LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines.
    de Guilhem de Lataillade A; Caillaud M; Oullier T; Naveilhan P; Pellegrini C; Tolosa E; Neunlist M; Rolli-Derkinderen M; Gelpi E; Derkinderen P
    J Neurochem; 2023 Jan; 164(2):193-209. PubMed ID: 36219522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14
    Ikezu T; Koro L; Wolozin B; Farraye FA; Strongosky AJ; Wszolek ZK
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):794-800. PubMed ID: 32180132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond.
    Bae JR; Lee BD
    BMB Rep; 2015 May; 48(5):243-8. PubMed ID: 25703537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson's Disease.
    Peter I; Strober W
    J Parkinsons Dis; 2023; 13(3):279-296. PubMed ID: 37066923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are LRRK2 mysteries lurking in the gut?
    de Guilhem de Lataillade A; Pellegrini C; Neunlist M; Rolli-Derkinderen M; Derkinderen P
    Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G429-G435. PubMed ID: 37643021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease?
    Herrick MK; Tansey MG
    NPJ Parkinsons Dis; 2021 Mar; 7(1):26. PubMed ID: 33750819
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.